US Stock MarketDetailed Quotes

KRON Kronos Bio

Watchlist
  • 0.867
  • -0.004-0.45%
Close Mar 24 16:00 ET
  • 0.855
  • -0.012-1.37%
Post 20:01 ET
52.84MMarket Cap-0.61P/E (TTM)

Kronos Bio Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
16.73%-65.44M
48.71%-12.84M
45.23%-12.37M
34.75%-16.33M
-301.87%-23.9M
13.58%-78.58M
-11.08%-25.02M
-0.86%-22.59M
-11.12%-25.03M
74.68%-5.95M
Net income from continuing operations
23.60%-86.08M
-1.95%-25.81M
55.03%-14.11M
45.53%-16.2M
-14.18%-29.96M
15.41%-112.67M
20.33%-25.32M
2.73%-31.37M
9.61%-29.74M
27.65%-26.24M
Depreciation and amortization
-19.66%1.72M
-14.44%409K
-19.22%412K
-27.46%420K
-16.52%475K
-5.74%2.14M
-16.72%478K
-10.68%510K
2.66%579K
2.15%569K
Other non cash items
-15.12%2.78M
-27.26%675K
-32.18%510K
0.88%803K
-0.88%790K
1.58%3.27M
25.75%928K
16.59%752K
-17.26%796K
-9.12%797K
Change In working capital
-404.51%-17.89M
0.53%-5.27M
-128.48%-740K
34.11%-3.29M
-163.32%-8.59M
-4.89%5.88M
-645.21%-5.29M
66.22%2.6M
-927.65%-5M
346.41%13.57M
-Change in prepaid assets
362.01%2.85M
118.46%120K
4,113.16%1.53M
60.29%1.65M
-264.23%-450K
-61.62%616K
-477.91%-650K
-106.23%-38K
147.00%1.03M
-32.51%274K
-Change in payables and accrued expense
3.16%-5.99M
52.40%-684K
-63.80%1.44M
41.12%-1.98M
11.16%-4.76M
-175.78%-6.18M
-190.66%-1.44M
50.40%3.98M
-542.24%-3.36M
-269.35%-5.36M
-Change in other current assets
-21.19%465K
18.32%465K
----
----
--0
155.92%590K
137.25%393K
----
----
-100.00%-2K
-Change in other current liabilities
--0
----
----
----
-1,200.00%-65K
-129.17%-42K
----
----
----
97.85%-5K
-Change in other working capital
-239.73%-15.22M
-45.22%-5.17M
-140.74%-3.71M
-13.31%-3.03M
-117.77%-3.32M
507.79%10.89M
-427.89%-3.56M
-28.68%-1.54M
-430.75%-2.68M
6,384.18%18.66M
Cash from discontinued investing activities
Operating cash flow
16.73%-65.44M
48.71%-12.84M
45.23%-12.37M
34.75%-16.33M
-301.87%-23.9M
13.58%-78.58M
-11.08%-25.02M
-0.86%-22.59M
-11.12%-25.03M
74.68%-5.95M
Investing cash flow
Cash flow from continuing investing activities
28.73%85.44M
-29.15%22.36M
-52.14%17.13M
647.60%40.18M
190.79%5.77M
305.97%66.37M
-0.55%31.56M
1,051.88%35.79M
113.19%5.37M
75.87%-6.36M
Net PPE purchase and sale
99.41%-4K
87.10%-4K
103.27%7K
--0
94.44%-7K
-17.68%-679K
40.38%-31K
-193.15%-214K
-258.14%-308K
65.57%-126K
Net investment purchase and sale
27.43%85.44M
-29.21%22.36M
-52.44%17.12M
607.07%40.18M
192.74%5.78M
311.87%67.05M
-0.62%31.59M
1,032.17%36M
113.98%5.68M
76.01%-6.23M
Cash from discontinued investing activities
Investing cash flow
28.73%85.44M
-29.15%22.36M
-52.14%17.13M
647.60%40.18M
190.79%5.77M
305.97%66.37M
-0.55%31.56M
1,051.88%35.79M
113.19%5.37M
75.87%-6.36M
Financing cash flow
Cash flow from continuing financing activities
-56.79%245K
-57.07%82K
-1K
-33.37%567K
126.68%191K
0
Proceeds from stock option exercised by employees
-56.79%245K
-57.07%82K
---1K
----
----
-33.37%567K
126.68%191K
--0
----
----
Cash from discontinued financing activities
Financing cash flow
-56.79%245K
-57.07%82K
---1K
-56.38%164K
--0
-33.37%567K
126.68%191K
--0
-8.29%376K
--0
Net cash flow
Beginning cash position
-14.93%66.35M
29.12%76.99M
55.60%72.23M
-26.60%48.22M
-14.93%66.35M
-61.06%78M
-14.22%59.63M
-47.35%46.42M
-56.49%65.7M
-61.06%78M
Current changes in cash
273.82%20.25M
42.81%9.61M
-63.97%4.76M
224.57%24.01M
-47.37%-18.13M
90.48%-11.65M
-20.78%6.73M
170.76%13.2M
69.33%-19.28M
75.04%-12.3M
End cash Position
30.51%86.6M
30.51%86.6M
29.12%76.99M
55.60%72.23M
-26.60%48.22M
-14.93%66.35M
-14.93%66.35M
-14.22%59.63M
-47.35%46.42M
-56.49%65.7M
Free cash flow
17.44%-65.44M
48.76%-12.84M
45.77%-12.36M
35.54%-16.33M
-293.64%-23.91M
13.38%-79.26M
-10.96%-25.06M
-1.48%-22.8M
-12.06%-25.33M
74.54%-6.07M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 16.73%-65.44M48.71%-12.84M45.23%-12.37M34.75%-16.33M-301.87%-23.9M13.58%-78.58M-11.08%-25.02M-0.86%-22.59M-11.12%-25.03M74.68%-5.95M
Net income from continuing operations 23.60%-86.08M-1.95%-25.81M55.03%-14.11M45.53%-16.2M-14.18%-29.96M15.41%-112.67M20.33%-25.32M2.73%-31.37M9.61%-29.74M27.65%-26.24M
Depreciation and amortization -19.66%1.72M-14.44%409K-19.22%412K-27.46%420K-16.52%475K-5.74%2.14M-16.72%478K-10.68%510K2.66%579K2.15%569K
Other non cash items -15.12%2.78M-27.26%675K-32.18%510K0.88%803K-0.88%790K1.58%3.27M25.75%928K16.59%752K-17.26%796K-9.12%797K
Change In working capital -404.51%-17.89M0.53%-5.27M-128.48%-740K34.11%-3.29M-163.32%-8.59M-4.89%5.88M-645.21%-5.29M66.22%2.6M-927.65%-5M346.41%13.57M
-Change in prepaid assets 362.01%2.85M118.46%120K4,113.16%1.53M60.29%1.65M-264.23%-450K-61.62%616K-477.91%-650K-106.23%-38K147.00%1.03M-32.51%274K
-Change in payables and accrued expense 3.16%-5.99M52.40%-684K-63.80%1.44M41.12%-1.98M11.16%-4.76M-175.78%-6.18M-190.66%-1.44M50.40%3.98M-542.24%-3.36M-269.35%-5.36M
-Change in other current assets -21.19%465K18.32%465K----------0155.92%590K137.25%393K---------100.00%-2K
-Change in other current liabilities --0-------------1,200.00%-65K-129.17%-42K------------97.85%-5K
-Change in other working capital -239.73%-15.22M-45.22%-5.17M-140.74%-3.71M-13.31%-3.03M-117.77%-3.32M507.79%10.89M-427.89%-3.56M-28.68%-1.54M-430.75%-2.68M6,384.18%18.66M
Cash from discontinued investing activities
Operating cash flow 16.73%-65.44M48.71%-12.84M45.23%-12.37M34.75%-16.33M-301.87%-23.9M13.58%-78.58M-11.08%-25.02M-0.86%-22.59M-11.12%-25.03M74.68%-5.95M
Investing cash flow
Cash flow from continuing investing activities 28.73%85.44M-29.15%22.36M-52.14%17.13M647.60%40.18M190.79%5.77M305.97%66.37M-0.55%31.56M1,051.88%35.79M113.19%5.37M75.87%-6.36M
Net PPE purchase and sale 99.41%-4K87.10%-4K103.27%7K--094.44%-7K-17.68%-679K40.38%-31K-193.15%-214K-258.14%-308K65.57%-126K
Net investment purchase and sale 27.43%85.44M-29.21%22.36M-52.44%17.12M607.07%40.18M192.74%5.78M311.87%67.05M-0.62%31.59M1,032.17%36M113.98%5.68M76.01%-6.23M
Cash from discontinued investing activities
Investing cash flow 28.73%85.44M-29.15%22.36M-52.14%17.13M647.60%40.18M190.79%5.77M305.97%66.37M-0.55%31.56M1,051.88%35.79M113.19%5.37M75.87%-6.36M
Financing cash flow
Cash flow from continuing financing activities -56.79%245K-57.07%82K-1K-33.37%567K126.68%191K0
Proceeds from stock option exercised by employees -56.79%245K-57.07%82K---1K---------33.37%567K126.68%191K--0--------
Cash from discontinued financing activities
Financing cash flow -56.79%245K-57.07%82K---1K-56.38%164K--0-33.37%567K126.68%191K--0-8.29%376K--0
Net cash flow
Beginning cash position -14.93%66.35M29.12%76.99M55.60%72.23M-26.60%48.22M-14.93%66.35M-61.06%78M-14.22%59.63M-47.35%46.42M-56.49%65.7M-61.06%78M
Current changes in cash 273.82%20.25M42.81%9.61M-63.97%4.76M224.57%24.01M-47.37%-18.13M90.48%-11.65M-20.78%6.73M170.76%13.2M69.33%-19.28M75.04%-12.3M
End cash Position 30.51%86.6M30.51%86.6M29.12%76.99M55.60%72.23M-26.60%48.22M-14.93%66.35M-14.93%66.35M-14.22%59.63M-47.35%46.42M-56.49%65.7M
Free cash flow 17.44%-65.44M48.76%-12.84M45.77%-12.36M35.54%-16.33M-293.64%-23.91M13.38%-79.26M-10.96%-25.06M-1.48%-22.8M-12.06%-25.33M74.54%-6.07M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.